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Acute disseminated encephalomyelitis (ADEM) is an
acute demyelinating disease occurring 1–3 wk after viral
infection or vaccination1,2. Although most patients with
ADEM make a full recovery, corticosteroids can be of
help in severe cases. Generally, the diagnosis of ADEM is
made by clinical history, neurological manifestations and
magnetic resonance images (MRI) of the central nervous
system. Neurological manifestations can occur both dur-
ing and after malarial infection, particularly Plasmodium
falciparum infection. These are infrequently encountered
in P. vivax though post-malaria neurological syndrome
(PMNS) has been reported from India3. ADEM has not
been recognized as a common neurological complication
of malaria. To the best of our knowledge only one case of
ADEM following treatment of P. vivax malaria has been
reported in literature4.
Case report
A female child aged 18 months, weighing 7.1 kg was
admitted with history of high grade fever and convulsion
for one day. Convulsion was generalized tonic, clonic in
nature, lasted for about 10 min. On arrival to our insti-
tute, the temperature was 38.5oC, pulse rate was 130/min,
respiratory rate was 30/min and blood pressure was 90/
60 mm of Hg. Respiratory, cardiovascular and pre-ab-
dominal examination was normal. On CNS examination,
the child was irritable with hypertonia which was spastic
in nature with more involvement of upper limb than lower
limb and babinski’s response. Laboratory investigations
showed Hb 10.3 g/dl, white blood cells (WBC) 23×103/μl
and platelets 350×103/μl .  Serum biochemistry including
C-reactive protein and blood sugar was normal. Rapid
malaria antigen test was positive for P. vivax and periph-
eral smear revealed ring form of P. vivax with >5% para-
sitemia. The cerebrospinal fluid (CSF) examination at that
time was normal. Child was started on Injection Artesunate
2.4 mg/kg/dose repeated after 12 and 24 h as per guide-
lines of the National Vector Borne Disease Control
Programme, India for treatment of severe malaria5. Child
became afebrile after 24 h. Her neurological examination
was also normal. Repeat peripheral smear after 24 and 48
h was negative. Child was discharged on artesunate com-
bination therapy (ACT) for 3 days. She was also advised
to take primaquine 0.25 mg/kg/day for 14 days.
After 7 days child was readmitted with fever and loss
of consciousness. Her Blantyre coma scale was 4 at that
time. She was also having right sided hemiparesis. Her
cranial nerve examination was found to be normal. Labo-
ratory investigation showed mild anemia with Hb of
9.1 g/dl, and normal WBC and platelet counts. Peripheral
smear was negative for malaria parasite on three occa-
sions. Serum biochemistry including blood sugar and elec-
trolytes were found to be normal. CSF examination showed
pleocytosis (70 cells/μl) with mild elevation of protein (50
mg/dl). CSF culture was sterile. Serology for herpes sim-
plex, Japanese encephalitis, measles and mumps virus was
found to be negative. Polymerase chain reaction (PCR)
analysis of viral nucleic acid in CSF was not done as the
facility for the same is not available at our centre. Acyclovir
(10 mg/kg/dose 3 times per day) and broad spectrum anti-
biotics Ceftriaxone (100 mg/kg divided in 2 doses) was
started keeping in view of the possibility of viral encepha-
litis or bacterial meningitis. Her consciousness level was
deteriorated and Blantyre coma scale was 2 in spite of treat-
ment. MRI brain was done after 72 h which showed dif-
fuse white matter hyper-intensities on T2 weighed images,
involving subcortical, deep and periventricular white mat-
ter and both external capsules (Fig. 1). She was diagnosed
as ADEM after P. vivax malaria based on her clinical
course, negative viral serology and MRI findings.  She
was given methyl prednisolone 30 mg/kg/day for 3 days
which was tapered to oral prednisolone and stopped after
2 wk. Ceftriaxone and acyclovir was stopped after MRI
report. She showed marked improvement after steroid, her
consciousness level as well as hemiparesis were improved.
Repeat MRI showed significant resolution of cortical and
deep white matter signal abnormality (Fig. 2). At the time
of discharge she was conscious, without any focal neuro-
logical deficit but  unable to walk. After 6 months follow
up child gradually started walking. J Vector Borne Dis 49, June 2012 120
DISCUSSION
Severe and complicated malaria is usually caused by
P. falciparum but it has been observed that P. vivax ma-
laria can also lead to severe disease. The reported cere-
bral and non-cerebral complications included cerebral ma-
laria, hepatic dysfunction, renal dysfunction, severe
anaemia, ARDS, shock, pulmonary oedema, hemoglobin-
uria, and multiple organ involvement6–8.
 Because of negative peripheral smear and sterile CSF,
initially, we suspected viral encephalitis in our patient.
The neurological symptoms resolved so rapidly after giv-
ing steroid in our patient so diagnosis of viral encephalitis
was very remote possibility. In ADEM patients, CSF pro-
tein is moderately elevated (50 to 150 mg/dl) and lympho-
cytic pleocytosis is generally present. MRI findings showed
diffuse hyper-intensities involving subcortical white mat-
ter, corpus callosum and brain stem. The findings of these
patient’s CSF and MRI as well as clinical course were
compatible with those of ADEM9. Plasmodium vivax in-
fection seemed to be a direct cause of ADEM from the
observed time course of her symptoms. Multiple sclerosis
(MS) is difficult to differentiate from ADEM. But as per
Pediatric MS Study Group child fits in ADEM as the dis-
ease was monophasic with clinical and MRI improvement
on follow up.
ADEM can be regarded as a complication of severe
malaria. Elevated level of neurotoxic cytokines in cere-
brospinal fluid, tumour necrosis factor-, interleukin 2
and 6 have been seen in a patient with severe malaria and
PMNS10. The latency of neurological involvement after
eradication of parasite and response to steroid treatment
in our patient support an immunological mechanism.
“PMNS is defined as symptomatic malaria infection
(initial blood smear positive for asexual forms of the para-
site), whose parasites have cleared from the peripheral
blood and, in cerebral cases, had recovered consciousness
fully, who developed neurological or psychiatric symp-
toms within two months of acute illness”. It is, therefore,
distinguished from cerebral malaria which occurs during
parasitemia. Patients with PMNS exhibit impaired con-
sciousness and multiple signs of cerebral involvement like
impaired consciousness, confusion, generalized seizure,
myoclonus, aphasia, tremor, and psychosis. PMNS is self-
limited, lasting 2–14 days, and requires no specific treat-
ment11.
 Several key features differentiate PMNS from delayed
cerebellar ataxia (DCA). PMNS is preceded by severe
malaria infection in most of the cases. Patients with PMNS
have impaired consciousness and multiple signs of cere-
bral involvement, while patients with DCA are fully con-
scious and alert at onset. Nearly one-third of patients with
DCA still had parasitemia at onset, while PMNS patients
do not have parasitemia. Patients with PMNS rarely de-
velop ataxia12.
Some authors draw parallels between ADEM and
PMNS2. We also consider possibilities that ADEM fol-
lowing Plasmodium infection explains the pathogenesis
of some cases of PMNS. We report a case of ADEM fol-
lowing P. vivax malaria. Further studies are required to
identify these two diseases. This case highlights the im-
portance that P. vivax malaria should be added to the list
of infections able to precipitate ADEM.
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